# Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection

> **NCT03312647** · — · UNKNOWN · sponsor: **Hanyang University** · enrollment: 1000 (estimated)

## Conditions studied

- Latent Tuberculosis Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03312647
- **Lead sponsor:** Hanyang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-19
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03312647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03312647, "Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03312647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*